FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Final Guidance on Good ANDA Submission

Federal Register notice: FDA makes available a final guidance entitled Good ANDA Submission Practices.

Marketing

FDA Cautions Lilly on Trulicity Social Media Post

The CDER Office of Prescription Drug Promotion says a Lilly social media post for Trulicity is false and misleading because it inadequately presents t...

Medical Devices

Pass Hearing Aid Rule Quickly: Grassley, Warren

Sens. Grassley and Warren urge FDA to quickly finalize its proposed rule on over-the-counter hearing aids.

Marketing

Companies Need Interactive Web Site Archives: Article

Hanzo compliance product manager Will Walker says companies need interactive Web archives to be able to show FDA how consumers viewed promotional mate...

FDA Responsibilities in New Preparedness Bill

FDA would have many responsibilities under bipartisan legislation drafted to improve the nations pandemic and public health preparedness released by S...

Federal Register

Device Guide on Patient-Reported Outcome Instruments

Federal Register notice: FDA makes available a medical device final guidance on principles for using patient-reported outcome instruments.

Federal Register

Guide on Patient Engagement in Device Trial Designs

Federal Register notice: FDA makes available a final guidance entitled Patient Engagement in the Design and Conduct of Medical Device Clinical Studies...

Medical Devices

ASCA 2021 Annual Report

CDRH issues its annual report on the Accreditation Scheme for Conformity Assessment pilot program.

Human Drugs

FDA Good ANDA Submission Practices Guidance

FDA publishes two guidances intended to help ANDA submissions.

Human Drugs

Incyte Pulling Parsaclisib NDA

Incyte says it is withdrawing an NDA for its parsaclisib to treat three lymphomas.